Extracorporeal cytokine adsorption for treating severe refractory cytokine release syndrome (CRS)

被引:0
|
作者
Florent Wallet
Emmanuel Bachy
Olivia Vassal
Arnaud Friggeri
Julien Bohe
Lorna Garnier
Gilles Salles
Bernard Allaouchiche
机构
[1] Lyon Sud Teaching hospital,Medical Intensive Care Unit, Hospices Civils de Lyon
[2] University of Lyon,Department of Hematology, Hospices Civils de Lyon
[3] Claude Bernard Lyon 1 University,Laboratory of Biology and Immunology, Hospices Civils de Lyon
[4] Lyon Sud Teaching hospital,undefined
[5] Lyon Sud Teaching hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2052 / 2055
页数:3
相关论文
共 50 条
  • [1] Extracorporeal cytokine adsorption for treating severe refractory cytokine release syndrome (CRS)
    Wallet, Florent
    Bachy, Emmanuel
    Vassal, Olivia
    Friggeri, Arnaud
    Bohe, Julien
    Garnier, Lorna
    Salles, Gilles
    Allaouchiche, Bernard
    BONE MARROW TRANSPLANTATION, 2020, 55 (10) : 2052 - 2055
  • [2] Update on Pediatric Cytokine Release Syndrome (CRS)
    Pao, Maryland
    PSYCHO-ONCOLOGY, 2023, 32 : 25 - 25
  • [3] Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome
    Stahl, Klaus
    Schmidt, Bernhard M. W.
    Hoeper, Marius M.
    Skripuletz, Thomas
    Mohn, Nora
    Beutel, Gernot
    Eder, Matthias
    Welte, Tobias
    Ganser, Arnold
    Falk, Christine S.
    Koenecke, Christian
    David, Sascha
    JOURNAL OF CRITICAL CARE, 2020, 57 : 124 - 129
  • [4] Cytokine adsorption in severe, refractory septic shock
    Pedro David Wendel Garcia
    Matthias Peter Hilty
    Ulrike Held
    Eva-Maria Kleinert
    Marco Maggiorini
    Intensive Care Medicine, 2021, 47 : 1334 - 1336
  • [5] Cytokine adsorption in severe, refractory septic shock
    Wendel Garcia, Pedro David
    Hilty, Matthias Peter
    Held, Ulrike
    Kleinert, Eva-Maria
    Maggiorini, Marco
    INTENSIVE CARE MEDICINE, 2021, 47 (11) : 1334 - 1336
  • [6] IDENTIFYING AND TREATING CYTOKINE RELEASE SYNDROME.
    Miller, Victoria
    Pandey, Prasamsa
    ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [7] Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome (CRS) with Teclistamab Administration
    Marin, Ellen
    Scott, Sara
    Maples, Kathryn
    Joseph, Nisha S.
    Hofmeister, Craig C.
    Gupta, Vikas A.
    Dhodapkar, Madhav V.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay K.
    BLOOD, 2023, 142
  • [8] Prophylactic Ruxolitinib for Cytokine Release Syndrome (CRS) in Relapse/Refractory (R/R) AML Patients Treated with Flotetuzumab
    Uy, Geoffrey L.
    Rettig, Michael P.
    Christ, Stephanie
    Aldoss, Ibrahim
    Byrne, Michael T.
    Erba, Harry P.
    Arellano, Martha L.
    Foster, Matthew C.
    Godwin, John E.
    Ravandi, Farhad
    Sayre, Peter H.
    Advani, Anjali S.
    Wieduwilt, Matthew J.
    Emadi, Ashkan
    Michaelis, Laura C.
    Stiff, Patrick J.
    Wermke, Martin
    Vey, Norbert
    Chevalier, Patrice
    Gyan, Emmanuel
    Recher, Christian
    Ciceri, Fabio
    Carrabba, Matteo Giovanni
    Curti, Antonio
    Huls, Geert
    Topp, Max S.
    Jongen-Lavrencic, Mojca
    Muth, John
    Curtis, Teia
    Collins, Mary Beth
    Timmeny, Erin
    Guo, Kuo
    Zhao, Jian
    Tran, Kathy
    Kaminker, Patrick
    Patel, Priyanka
    Bakkacha, Ouiam
    Jacobs, Kenneth
    Kostova, Maya
    Seiler, Jennifer
    Lowenberg, Bob
    Rutella, Sergio
    Walter, Roland B.
    Bonvini, Ezio
    Davidson-Moncada, Jan K.
    DiPersio, John F.
    BLOOD, 2020, 136
  • [9] Tocilizumab-Refractory Cytokine Release Syndrome (CRS) Triggered By Chimeric Antigen Receptor (CAR)-Transduced T Cells May Have Distinct Cytokine Profiles Compared to Typical CRS
    Ishii, Kazusa
    Shalabi, Haneen
    Yates, Bonnie
    Delbrook, Cindy
    Mackall, Crystal L.
    Fry, Terry J.
    Shah, Nirali N.
    BLOOD, 2016, 128 (22)
  • [10] Cytokine release syndrome in severe COVID-19
    Moore, John B.
    June, Carl H.
    SCIENCE, 2020, 368 (6490) : 473 - 474